Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jaime Kulisevsky

Showing results (1-10 of 297) with videos related to

Pageof 30
Sort By:
European Neurology|December 3, 2011
Adenosine A2A-receptor antagonism and pathophysiology of Parkinson's disease and drug-induced movement disordersJaime Kulisevsky, Michael Poyurovsky
Neurology|October 27, 2004
Hallucinations and sleep disturbances in Parkinson's diseaseJaime Kulisevsky, Eliana Roldan
Advances in Therapy|December 9, 2023
The Effects of Safinamide in Chinese and Non-Chinese Patients with Parkinson's DiseaseCarlo Cattaneo, Jaime Kulisevsky
International Review of Neurobiology|August 14, 2017
Apathy in Parkinson's DiseaseJavier Pagonabarraga, Jaime Kulisevsky
Therapeutic Advances in Neurological Disorders|December 24, 2010
Diagnosis and management of essential tremor and dystonic tremorAlexandre Gironell, Jaime Kulisevsky
Drug Safety|January 20, 2010
Tolerability and safety of ropinirole versus other dopamine agonists and levodopa in the treatment of Parkinson's disease: meta-analysis of randomized controlled trialsJaime Kulisevsky, Javier Pagonabarraga
Neurology|October 27, 2012
Advances with MRI in Parkinson disease: from freezing to festinationMassimo Filippi, Jaime Kulisevsky
Journal of Neuroimaging : Official Journal of the American Society of Neuroimaging|September 10, 2021
Intracortical surface-based MR diffusivity to investigate neurologic and psychiatric disorders: a reviewFrederic Sampedro, Jaime Kulisevsky
Movement Disorders : Official Journal of the Movement Disorder Society|April 9, 2009
Cognitive impairment in Parkinson's disease: tools for diagnosis and assessmentJaime Kulisevsky, Javier Pagonabarraga
Current Genomics|February 18, 2014
Parkinson's disease: from genetics to clinical practiceJordi Clarimón, Jaime Kulisevsky
Pageof 30

Showing results (1-10 of 297) with videos related to

Sort By:
Pageof 30
European Neurology|December 3, 2011
Adenosine A2A-receptor antagonism and pathophysiology of Parkinson's disease and drug-induced movement disordersJaime Kulisevsky, Michael Poyurovsky
Neurology|October 27, 2004
Hallucinations and sleep disturbances in Parkinson's diseaseJaime Kulisevsky, Eliana Roldan
Advances in Therapy|December 9, 2023
The Effects of Safinamide in Chinese and Non-Chinese Patients with Parkinson's DiseaseCarlo Cattaneo, Jaime Kulisevsky
International Review of Neurobiology|August 14, 2017
Apathy in Parkinson's DiseaseJavier Pagonabarraga, Jaime Kulisevsky
Therapeutic Advances in Neurological Disorders|December 24, 2010
Diagnosis and management of essential tremor and dystonic tremorAlexandre Gironell, Jaime Kulisevsky
Drug Safety|January 20, 2010
Tolerability and safety of ropinirole versus other dopamine agonists and levodopa in the treatment of Parkinson's disease: meta-analysis of randomized controlled trialsJaime Kulisevsky, Javier Pagonabarraga
Neurology|October 27, 2012
Advances with MRI in Parkinson disease: from freezing to festinationMassimo Filippi, Jaime Kulisevsky
Journal of Neuroimaging : Official Journal of the American Society of Neuroimaging|September 10, 2021
Intracortical surface-based MR diffusivity to investigate neurologic and psychiatric disorders: a reviewFrederic Sampedro, Jaime Kulisevsky
Movement Disorders : Official Journal of the Movement Disorder Society|April 9, 2009
Cognitive impairment in Parkinson's disease: tools for diagnosis and assessmentJaime Kulisevsky, Javier Pagonabarraga
Current Genomics|February 18, 2014
Parkinson's disease: from genetics to clinical practiceJordi Clarimón, Jaime Kulisevsky
Pageof 30